share_log

Shattuck Labs | 4: Statement of changes in beneficial ownership of securities-Officer Pandite Arundathy N.

SEC announcement ·  Jan 16 13:00
Summary by Futu AI
On January 10, 2024, Arundathy N. Pandite, the Chief Medical Officer of Shattuck Labs, Inc., completed a series of transactions involving the company's common stock. Pandite acquired 46,475 shares at no cost, which is typically indicative of a grant or award. On the same day, she disposed of 2,987 shares at a price of $10.09 per share, a transaction often associated with the payment of exercise price or tax liability by delivering or withholding securities. Following these transactions, Pandite's direct holdings in Shattuck Labs totaled 219,280 shares. The total market value of the disposed shares amounted to $30,138.83.
On January 10, 2024, Arundathy N. Pandite, the Chief Medical Officer of Shattuck Labs, Inc., completed a series of transactions involving the company's common stock. Pandite acquired 46,475 shares at no cost, which is typically indicative of a grant or award. On the same day, she disposed of 2,987 shares at a price of $10.09 per share, a transaction often associated with the payment of exercise price or tax liability by delivering or withholding securities. Following these transactions, Pandite's direct holdings in Shattuck Labs totaled 219,280 shares. The total market value of the disposed shares amounted to $30,138.83.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.